Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Digital Ulcers in Systemic Sclerosis
NCT00624273Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in digital ulcer (DU), systemic sclerosis (SSc), sponsored by Charité – Universitätsmedizin Berlin. Started Feb 2004; status: completed.
02
Drugs
ASP-001
03
Conditions
digital ulcer (DU)systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT00624273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00624273.